Pharmaceutical Technology

APRIL 20, 2023

This is one of several patent infringement cases Amgen has pursued in recent years to stave competition. Despite this legal win, Amgen still faces a competitive psoriasis market as other drugs enter the landscape. The FDA first approved Otezla in March 2014 for the treatment of psoriatic arthritis. Patent No.

Competition 52

Competition Marketing FDA Prospecting 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

CloserIQ

OCTOBER 10, 2018

Founded 2014. Drift provides a conversational sales and marketing platform that allows businesses to better connect with prospects and customers. Founded 2014. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2014. Founded 2014.

Sales 76

Sales Management Marketing Education 76

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

FEBRUARY 6, 2023

The FDA approved both drugs in 2014. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. In the US, the annual cost for Esbriet is $113,193 and $112,357 for Ofev.

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

Pharmaceutical Technology

DECEMBER 19, 2022

billion in equity since it started in 2014. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. ” This $1.5

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69